Free Trial

Sangoma Technologies (SANG) Earnings Date, Estimates & Call Transcripts

Sangoma Technologies logo
$6.25 -0.11 (-1.73%)
(As of 11/20/2024 ET)

Sangoma Technologies Latest Earnings Summary

Upcoming Q1
Earnings Date
Feb. 13Estimated
Actual EPS
(Sep. 18)
-$0.05 Missed By -$0.01
Consensus EPS
(Sep. 18)
-$0.04

Sangoma Technologies announced Q4 2024 earnings on September 18, 2024, reporting an EPS of -$0.05, which missed the consensus estimate of -$0.04 by $0.01. Quarterly revenue was reported to be $60.93 million, above analysts' expectations of $60.89 million. With a trailing EPS of -$0.25, Sangoma Technologies' earnings are expected to grow next year, from ($0.06) to $0.09 per share.

SANG Upcoming Earnings

Sangoma Technologies' next earnings date is estimated for Thursday, February 13, 2025, based off prior year's reporting schedules.

Get Sangoma Technologies Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Sangoma Technologies and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SANG Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SANG Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Sangoma Technologies Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.10-$0.10-$0.10
Q2 20241-$0.08-$0.08-$0.08
Q3 20241-$0.08-$0.08-$0.08
Q4 20241-$0.04-$0.04-$0.04
FY 20244-$0.30-$0.30-$0.30
Q1 20251-$0.04-$0.04-$0.04
Q2 20251-$0.05-$0.05-$0.05
Q3 20251-$0.03-$0.03-$0.03
Q4 20251$0.04$0.04$0.04
FY 20254($0.08)($0.08)($0.08)

Sangoma Technologies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/13/2025
(Estimated)
------- 
9/18/2024Q4 2024-$0.04-$0.05 -$0.01-$0.05$60.89M$60.93M  
5/8/2024Q3 2024-$0.05-$0.04+$0.01-$0.04$61.09M$61.05M
2/8/2024Q2 2024-$0.09-$0.10 -$0.01-$0.10$63.60M$62.28M
11/8/2023Q1 2024-$0.10-$0.07+$0.03-$0.07$63.78M$63.03M
9/27/2023Q4 2023-$0.05-$0.04+$0.01$0.64$62.58M$63.68M
5/11/2023Q3 2023-$0.06-$0.02+$0.04-$0.02$63.24M$62.76M
2/9/2023Q2 2023-$0.08-$0.08--$0.08$67.12M$62.04M

Sangoma Technologies Earnings - Frequently Asked Questions

Sangoma Technologies has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based off last year's report dates. Learn more on SANG's earnings history.

Sangoma Technologies issued an update on its FY 2025 earnings guidance on Thursday, November, 7th. The company issued revenue guidance of $250.0 million-$260.0 million, compared to the consensus revenue estimate of $63.1 million.

In the previous quarter, Sangoma Technologies (NASDAQ:SANG) missed the analysts' consensus estimate of ($0.04) by $0.01 with a reported earnings per share (EPS) of ($0.05). Learn more on analysts' earnings estimate vs. SANG's actual earnings.

The conference call transcript for Sangoma Technologies's latest earnings report can be read online.
Read Transcript

Sangoma Technologies (NASDAQ:SANG) has a recorded annual revenue of $244.41 million.

Sangoma Technologies (NASDAQ:SANG) has a recorded net income of -$8.66 million. SANG has generated -$0.25 earnings per share over the last four quarters.

Sangoma Technologies's earnings are expected to grow from ($0.06) per share to $0.09 per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:SANG) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners